According to Goldstein Research, as large share of population i.e. more than 90% is at risk of infection in Africa and South East Asia would be a major breakthrough for malaria vaccine market.
Global malaria vaccine market has been classified on the basis of vaccine type, agents and end users. Among end users government institutes dominate the global malaria vaccine market followed by hospitals, labs and NGO’s.
Global malaria vaccine market valued USD 0.07 billion in 2016 and is expected to reach USD 0.6 billion by 2024 at a modest CAGR over the forecast period. Malaria is widespread and kills one African child every 30 seconds, leading cause of death among under-fives in many countries. There exists a large unrealized market especially in Africa, Asia Pacific, Latin America and Middle East.
Projects focusing on Pre-erythrocytic Approach
The R&D field of malaria vaccine is evolving day by day towards the most advanced and relevant version of treatment. Pre-erythrocytic method aims to trigger immune defense mechanism as soon as infected female injects into the bloodstream or liver cells of the individual. This halts the parasite to infect, mature and multiply in the individual. Transmission blocking vaccines are also in developing phase which would not prevent people from getting malaria but limit the spread of infection in the body.
“Global Malaria Vaccine Market 2024” contains detailed overview of the global Malaria vaccine market in terms of market segmentation by vaccine type, agent, end user and geographies.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.
Global Malaria vaccine market also provides competitive outlook of some of the major players of the global malaria vaccine market which includes profiling of companies such as GlaxoSmithKline plc, Sanaria Inc, Nobelpharma Co., Sumaya Biotech and GenVec Inc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.
Overall, the report represents comprehensive synopsis on the global malaria vaccine market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Backed up by reliable research and impactful statistics, our business solutions empower our clients to grow at a fast pace despite unsettling fluctuations in the market. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.